Streetbeat News

Analyst Ratings

LRCX

A significant amount of unusual options activity has been observed for Lam Research (NASDAQ:LRCX), with a majority of investors taking a bearish stance. The price range targeted by these investors over the last three months is between $300 and $720. Wolfe Research has downgraded its action to Outperform with a price target of $825. The next earnings are expected to be released in 16 days.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 5:16 pm

SPWR

Susquehanna analyst Biju Perincheril maintains a positive outlook on SunPower (NASDAQ:SPWR), but has lowered the price target from $14 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 5:12 pm

SEDG

Susquehanna analyst Biju Perincheril maintains a positive outlook on SolarEdge Technologies (NASDAQ:SEDG), but has lowered the price target from $305 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 5:10 pm

RUN

Susquehanna analyst Biju Perincheril maintains a positive outlook on Sunrun (NASDAQ:RUN), but has lowered the price target from $33 to $26.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 5:09 pm

NOVA

Susquehanna analyst Biju Perincheril maintains a positive outlook on Sunnova Energy Intl (NYSE:NOVA), but has lowered the price target from $32 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 5:06 pm

ENPH

Susquehanna analyst Biju Perincheril has maintained a positive rating on Enphase Energy (NASDAQ:ENPH) but lowered the price target from $200 to $175.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 5:05 pm

UNH

A significant bearish stance has been taken on UnitedHealth Group (NYSE:UNH) by a large investor or institution, as indicated by unusual options trades. The sentiment among these big-money traders is 83% bearish. The whales have been targeting a price range from $450.0 to $540.0 for UnitedHealth Group over the last 3 months. Cantor Fitzgerald and HSBC have downgraded their actions on UNH with price targets of $591 and $540 respectively.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 5:01 pm

SCHW

A significant bearish stance has been observed in Charles Schwab's (NYSE:SCHW) options activity, with 75% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $42.5 to $55.0 for Charles Schwab over the last 3 months. JMP Securities downgraded its action to Market Outperform with a price target of $77, Barclays maintained their Equal-Weight rating with a price target of $64, and Raymond James maintained their Outperform rating with a price target of $72.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 5:01 pm

EFX

Equifax (NYSE:EFX) has received mixed ratings from analysts in the last quarter, with 3 somewhat bullish, 2 indifferent, and 1 somewhat bearish. The average price target is $226.0, representing an upside from the current price of $178.69. However, this is a 2.16% decrease from the previous average price target of $231.00.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 5:00 pm

ZBH

Analysts have provided various ratings for Zimmer Biomet Holdings (NYSE:ZBH) in the last quarter, with 1 bullish, 2 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The company has an average 12-month price target of $142.75, up by 1.67% from the previous average of $140.40.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 5:00 pm